Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2020.02.014 ◽

2020 ◽

Vol 18 (10) ◽

pp. 2295-2304.e2 ◽

Author(s):

Charlotte Rose Hawkey Hedin ◽

Gina Sado ◽

Nelson Ndegwa ◽

Ellina Lytvyak ◽

Andrew Mason ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Sa1897 Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

Gastroenterology ◽

10.1016/s0016-5085(16)31386-5 ◽

2016 ◽

Vol 150 (4) ◽

pp. S396-S397 ◽

Author(s):

Ramprasad Jegadeesan ◽

Gursimran Kochhar ◽

Umar Hayat ◽

Ahyoung J. Kim ◽

Nan Lan ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Primary Sclerosing Cholangitis ◽

Bowel Disease ◽

Sclerosing Cholangitis ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Necrosis Factor ◽

Tumor Necrosis Factor Treatment

Download Full-text

HLA-DRB1 and tumor necrosis factor a but not cystic fibrosis transmembrane conductance regulator genes contribute to the genetic susceptibility of primary sclerosing cholangitis

Gastroenterology ◽

10.1016/s0016-5085(08)82849-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A573

Author(s):

Giulia M. Cavestro ◽

Pletro Seghini ◽

Tauro M. Neri ◽

Paola F. Zanelli ◽

Mauro Podda ◽

...

Keyword(s):

Cystic Fibrosis ◽

Tumor Necrosis Factor ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

Tumor Necrosis ◽

Transmembrane Conductance Regulator ◽

Transmembrane Conductance ◽

Regulator Genes ◽

Cystic Fibrosis Transmembrane ◽

Necrosis Factor

Download Full-text

Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis

Journal of Hepatology ◽

10.1016/s0168-8278(99)80068-3 ◽

1999 ◽

Vol 30 (2) ◽

pp. 237-241 ◽

Author(s):

William Bernal ◽

Manus Moloney ◽

James Underhill ◽

Peter T Donaldson

Keyword(s):

Tumor Necrosis Factor ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

Tumor Necrosis ◽

Necrosis Factor

Download Full-text

HLA-DRB1 and tumor necrosis factor a but not cystic fibrosis transmembrane conductance regulator genes contribute to the genetic susceptibility of primary sclerosing cholangitis

Gastroenterology ◽

10.1016/s0016-5085(01)82849-3 ◽

2001 ◽

Vol 120 (5) ◽

pp. A573-A573 ◽

Author(s):

G CAVESTRO ◽

P SEGHINI ◽

T NERI ◽

P ZANELLI ◽

M PODDA ◽

...

Keyword(s):

Cystic Fibrosis ◽

Tumor Necrosis Factor ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis ◽

Tumor Necrosis ◽

Transmembrane Conductance Regulator ◽

Transmembrane Conductance ◽

Regulator Genes ◽

Cystic Fibrosis Transmembrane ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160775.622184 ◽

2009 ◽

Author(s):

Cyrus Tamboli

Keyword(s):

Tumor Necrosis Factor ◽

Drug Administration ◽

Safety Assessment ◽

Tumor Necrosis ◽

Food And Drug Administration ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726749172.793568149 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732092122.793568144 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Gastroenterology ◽

10.1053/j.gastro.2017.11.204 ◽

2018 ◽

Vol 154 (1) ◽

pp. S81-S82

Author(s):

Siddharth Singh ◽

John George ◽

Brigid S. Boland ◽

Niels Vande Casteele ◽

William J. Sandborn

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumor Necrosis ◽

Meta Analysis ◽

Second Line ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2016.08.044 ◽

2017 ◽

Vol 15 (2) ◽

pp. 229-239.e5 ◽

Author(s):

Brian G. Feagan ◽

David T. Rubin ◽

Silvio Danese ◽

Severine Vermeire ◽

Brihad Abhyankar ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Treatment with Tumor Necrosis Factor Antagonists and Their Possible Effects on Morbidity and Mortality in Psoriasis Patients

Psoriasis Forum ◽

10.1177/247553031117a00106 ◽

2011 ◽

Vol 17a (1) ◽

pp. 56-62

Author(s):

Margarita Carlos ◽

Melanie Ortleb

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Morbidity And Mortality ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text